Steve Gallup

Rare Disease Territory Business Manager @argenx

Berkeley, CA, US
EMAILS
s••••••@argenx.com
MOBILE NUMBERS
+14•••••••09

Signup · Get unlimited contacts

WORK HISTORY

Sep 2021 — Present

Rare Disease Territory Business Manager @argenx

View department →

Market preparation and launch of novel neuromuscular rare disease therapy. Member of US GM council, providing trusted feedback to senior leadership and collaborating on long term cultural development.

EDUCATION

N/A

UC Santa Barbara

BS, Pharmacology

SKILLS

BiotechnologyHospital SalesPulmonologyMedical AffairsVaccinesOncologyNeurologyInfectious DiseasesPharmaceutical SalesLeadershipGastroenterologyPharmaceutical IndustryManaged CareClinical ResearchMonoclonal AntibodiesCardiologyRare Diseases

ABOUT STEVE GALLUP

Rare Disease Account Manager with broad experience working with academic medical centers, key opinion leaders, managed care organizations and specialty pharmacy distributors. Experience with rare diseases, FcRN Antagonists, antisense oligonucleotide therapy, enzyme replacement therapy, subcutaneous injectables and infusion products, intrathecal products, and monoclonal antibodies. Extensive experience with successful new product launches in a startup environment. Expanded access to diagnostic testing for rare diseases and developed advocates in the medical and patient communities. Led successful five person sales team. Winner of two Golden Fleece awards at argenx for top sales and top team performance in 2023 year. 2017, 2018 and 2020 President\'s Club Award winner for Biogen Rare Disease (SMA). Winner of four previous CEO/President\'s Club Awards as well as Clinical Marketing Manager of the Year at MedImmune. Strong clinical presentation skills and customer focused sales background. Emphasis on cross functional partnerships and a deep, entrepreneurial account management approach. Specialties: Rare diseases, neuromuscular disease, Spinal Muscular Atropy, Myasthenia Gravis, genetics and genetic testing, lysosomal storage diseases, antisense oligonucleotides (ASO\'s), enzyme replacement therapy (ERT), infectious diseases, monoclonal antibodies, managed care, Kaiser, leadership, IV and injectable products, intrathecal injections, development stage products, key accounts, thought leaders, specialty pharmacy, buy and bill, procurement, managing work in a virtual environment.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.